News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
TUCHMAN ALAN J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/20/2022 |
4
| TUCHMAN ALAN J (CEO) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Sold 27,000 shares
@ $1.1719, valued at
$31.6k
|
|
| 12/01/2022 |
4/A
| TUCHMAN ALAN J (CEO) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 68,850 options to buy
@ $6.07, valued at
$417.9k
|
|
| 11/17/2022 |
4
| TUCHMAN ALAN J (CEO) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 112,000 options to buy
@ $6.07, valued at
$679.8k
|
|
| 02/22/2022 |
4
| TUCHMAN ALAN J (CEO) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Granted 6,150 options to buy
@ $7.29, valued at
$44.8k
|
|
| 07/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/18/2009 |
4
| TUCHMAN ALAN J (Director) has filed a Form 4 on Cordex Pharma, Inc.|
Txns:
| Granted 1,750 options
@ $0.2, valued at
$350 |
|
| 04/08/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|